Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
ARK’s Wood predicts a deflationary tech boom, an inverted yield curve that will not lead to an economic recession, and bitcoin will play a more significant role.

ARK’s Wood predicts a deflationary tech boom, an inverted yield curve that will not lead to an economic recession, and bitcoin will play a more significant role.

MpostMpost2026/10/08 16:43
Show original

In Brief

Cathie Wood of ARK Invest states that artificial intelligence, robotics, blockchain, and energy storage technologies can boost productivity by 5-6%, driving a deflationary boom beneficial for stocks and Bitcoin.

Cathie Wood, CIO and portfolio manager of ARK Invest, believes that five converging innovation platforms—artificial intelligence, robotics, energy storage, blockchain, and multiomics—could drive sustainable US productivity growth up to 5% to 6%, far above the 2% to 3% that investors have grown accustomed to since the Industrial Revolution. In her latest letter to investors, Wood points out that the real GDP annual growth rate could exceed 7%. She believes this scenario resembles the fifty-year expansion marked by the “Roaring Twenties,” rather than any other period over the past century.

Wood describes the current environment as a “back to the future” situation: after interest rates plunged to near zero during the COVID shock, they are now rising in a pattern similar to the pre-Federal Reserve era, when short-term rates tracked nominal GDP growth while long-term rates reflected the deflationary undercurrents of technology. During the Industrial Revolution, the probability of yield curve inversion exceeded 60%, but it did not signal a recession. ARK believes that a similar inversion today will be a positive indicator for the stock market, not a warning signal.

Wood writes that the core driving force is the dramatic decline in technology costs. Since the advent of cloud computing and the breakthroughs in deep learning over the past decade, the cost of AI inference has fallen more than 99% annually. The price of whole genome sequencing has dropped from $270 million in 2003 to under $100. This “benign deflation” has already begun to show macroeconomic effects: ARK notes that by 2025, demand for AI inference will grow about 25 times, and estimates that Anthropic’s annualized revenue surged from $9 billion to $65 billion between last December and this July. In ARK’s view, this impressive growth strongly refutes claims of an AI speculation bubble.

Inflation, Oil, and Reasons to Invest in Stocks

Regarding inflation, Wood points out that other data suggest official numbers overstate the problem. In July, the government reported headline and core personal consumption expenditures (PCE) at 3.7% and 3.3% respectively, while the Truflation index, which tracks over 16 million prices daily, showed headline PCE at 2.5% and core PCE at 2.1%, both very close to the Federal Reserve’s 2% target. Wood believes part of the difference comes from energy prices: gasoline prices rose about 33% year-on-year due to the Iran war, but she expects prices will fall sharply once the conflict eases—potentially to $30–$35 per barrel—citing surging output from the UAE and other oil producers exceeding their quota limits.

Wood believes monetary policy reinforces this outlook. With Kevin Warsh becoming Federal Reserve Chair, she expects the Fed will implement Volcker-style monetary discipline, inflation will decline, and as productivity boosts the dollar, gold prices may fall—though she also notes that Bitcoin can serve alongside gold as a tool to hedge counterparty risk in volatile markets.

This outlook is not without risk. If short-term rates rise to 6%–8% as ARK predicts, then roughly $16 trillion in private equity and private credit (most of it financed with floating rate debt) could face severe pressure; meanwhile, in this scenario, federal debt repayments would surge by about $80 billion.

Wood concludes with a call for portfolio reallocation: she believes that the classic 60/40 investment model was fit for the era of falling rates from 1981 to 2021, but a deflationary tech boom requires a higher weighting in equities—particularly in Bitcoin for investors focused on cryptocurrencies.

News Image 0
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Tobacco and alcohol stocks lead gains in the consumer staples sector

On October 8, Thursday, Philip Morris International (PM.N) became the top gainer in the S&P 500 Consumer Staples sector (.SPLRCS), followed by alcoholic beverage company Constellation Brands (STZ.N) and Altria Group (MO.N), both ranking among the day's biggest gainers. Shares of Philip Morris International (PM), a supplier of cigarettes and smoke-free nicotine products, rose about 4% to $200.89, set for a fourth consecutive session of gains and marking the largest single-day increase since July 16. Marlboro cigarette maker Altria gained 2.9% to $71.36. Earlier, British peer Imperial Brands (IMB.L) said it expects to meet its full-year guidance and announced a £1.5 billions ($1.98 billions) share buyback plan, as robust growth in tobacco alternatives helped offset declining cigarette sales. STZ, which produces beer, wine, and spirits, rose over 3% to $122.35 on the second trading day after releasing its quarterly report, despite several brokerages lowering their price targets. JPMorgan, however, raised its target from $133 to $136. Cetera Chief Investment Officer Gene Goldman noted on Thursday that there is “a rotation from growth stocks to defensive stocks” in the market, adding that “rising yields and wider credit spreads are putting pressure on AI and growth stocks.” He also pointed out that valuations in the sector are improving. Over the past three months, the sector has underperformed the broader S&P 500, falling 1% versus the benchmark’s 3.9% rise. Among the five S&P sectors that did not decline on Thursday, the Consumer Staples Index posted the second-largest gain, up 1.6%.

路透社•2026/10/08 17:06

US Stock Movement | SuperX AI Technology (SUPX.US) once fell more than 2.5%, hitting an intraday low of $6.46

SuperX AI Technology's stock price declined, falling more than 2.5% at one point.

智通财经•2026/10/08 16:11

BUZZ-Pacira BioSciences participated in a Viatris acquisition deal worth 1.65 billions dollars

Latest Update October 8 – Pacira BioSciences (PCRX.O) shares surged by 44%, hitting a more than three-year high at $36.30. If the rally holds, PCRX is poised for its largest single-day gain on record. Pharmaceutical company Viatris (VTRS.O) will acquire Pacira BioSciences in a $1.65 billion cash deal, offering $36.50 per share. The offer represents a premium of approximately 44.8% over Pacira’s recent closing price of $25.20. The transaction will add Pacira’s non-opioid pain medications Exparel and Zilretta to Viatris' product portfolio. Viatris shares fell 2.6% to $17.04. JPMorgan stated: “We believe this acquisition will not significantly alter VTRS' overall financial profile in the short or long term, and expect Exparel’s sales to gradually decline post-2030 due to generic market entry.” Both parties expect to complete the transaction by the end of 2026. Including intraday fluctuations, PCRX shares have risen 40.2% year-to-date, while VTRS has gained 36.8%. (For the convenience of non-English speakers, Reuters provides automated translations of its reports into several other languages. As automated translation may contain errors or lack the necessary context, Reuters does not guarantee the accuracy of automated translated texts and provides them for readers’ convenience only. Reuters assumes no liability for any damage or losses resulting from the use of automated translation.)

路透社•2026/10/08 16:11